As VEGF is the main mediator of angiogenesis in many types of cancer to cater to chronic hypoxic conditions and as VEGF is under control of HIF signaling, it is also aberrantly expressed in lung cancer (166), in particular in adenocarcinoma (167). Here, VEGFA is linked to lung cancer.